INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 183 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $49,000 | -89.8% | 28,143 | -67.5% | 0.00% | -100.0% |
Q3 2018 | $482,000 | +21.4% | 86,665 | -14.4% | 0.00% | +50.0% |
Q2 2018 | $397,000 | +25.2% | 101,225 | +50.2% | 0.00% | 0.0% |
Q1 2018 | $317,000 | +66.0% | 67,400 | +137.3% | 0.00% | 0.0% |
Q4 2015 | $191,000 | – | 28,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |